As of January 22, 2025, Silence Therapeutics (SLN) has a market cap of $0.26 billion USD. According to our data, Silence Therapeutics is ranked No.6855 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.26 B |
-21.08%
|
Dec 31, 2024 | $0.32 B |
-60.39%
|
Dec 29, 2023 | $0.82 B |
13.90%
|
Dec 30, 2022 | $0.72 B |
-36.17%
|
Dec 31, 2021 | $1.13 B |
8.59%
|
Dec 31, 2020 | $1.04 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Arrowhead Pharmaceuticals
ARWR
|
$2.45 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Arcturus Therapeutics
ARCT
|
$0.45 B |
0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Telesis Bio
TBIO
|
$0.53 M |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Market Cap | = | SLN Stock Price | * | SLN Shares Outstanding |
= | $5.43 | * | 47.21 M | |
= | $0.26 B |